Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.07)
# 477
Out of 5,172 analysts
352
Total ratings
42.94%
Success rate
15.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $28.46 | +75.69% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $3.34 | +259.28% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $312.17 | +82.59% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $5.41 | +639.37% | 17 | Aug 4, 2025 | |
| ATAI AtaiBeckley | Maintains: Buy | $10 → $15 | $3.49 | +329.80% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $21.47 | -53.42% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.38 | +262.32% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.33 | +2,914.77% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $6.17 | +1,115.56% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $29.91 | +234.34% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $16.09 | +335.05% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.95 | +426.32% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $6.52 | +820.25% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $56.33 | +42.02% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $13.97 | +186.33% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.85 | +680.23% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $27.72 | +152.53% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $24.63 | +224.81% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.36 | +635.29% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.42 | +2,267.42% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $9.10 | +1,108.79% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $71.62 | +18.68% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $10.98 | +519.31% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $73.85 | +360.39% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $28.46
Upside: +75.69%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $3.34
Upside: +259.28%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $312.17
Upside: +82.59%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $5.41
Upside: +639.37%
AtaiBeckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $3.49
Upside: +329.80%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $21.47
Upside: -53.42%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.38
Upside: +262.32%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.33
Upside: +2,914.77%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $6.17
Upside: +1,115.56%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $29.91
Upside: +234.34%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $16.09
Upside: +335.05%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.95
Upside: +426.32%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $6.52
Upside: +820.25%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $56.33
Upside: +42.02%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $13.97
Upside: +186.33%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $3.85
Upside: +680.23%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $27.72
Upside: +152.53%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $24.63
Upside: +224.81%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.36
Upside: +635.29%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.42
Upside: +2,267.42%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $9.10
Upside: +1,108.79%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $71.62
Upside: +18.68%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $10.98
Upside: +519.31%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $73.85
Upside: +360.39%